Therapeutic Asset Ratings
395 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
[18f]psma-pet
Prostate Cancer
Region Västerbotten
P3
CCC
(50)
1H-BENZIMIDAZOLE, 2-(((4-(3-METHOXYPROPOXY)-3-METHYL-2-PYRIDINYL)METHYL)SULFINYL)-, SODIUM SALT, HYDRATE (1:1:1)
Prostate Cancer
AstraZeneca
P3
CCC
(50)
FLORASTAMIN
Prostate Cancer
HTA Co., Ltd.
P3
CCC
(50)
Ifinatamab Deruxtecan
Prostate Cancer
Merck Sharp & Dohme LLC
P3
CCC
(50)
Lorazepam
Prostate Cancer
Merck Sharp & Dohme LLC
P3
CCC
(50)
ra223
Prostate Cancer
European Organisation for Research and Treatment of Cancer - EORTC
P3
CCC
(50)
Radiopharmaceutical 18F-Jk-Psma-7
Prostate Cancer
ITEL Telecomunicazioni Srl
P3
CCC
(50)
Zanzalintinib
Prostate Cancer
Exelixis
P3
CCC
(50)
64cu-dota-ae105
Prostate Cancer
Curasight
P2
CCC
(50)
asp5541
Prostate Cancer
Astellas Pharma Global Development, Inc.
P2
CCC
(50)
bz371a
Prostate Cancer
Biozeus Biopharmaceutical S.A.
P2
CCC
(50)
Dapagliflozin
Prostate Cancer
Yung NA
P2
CCC
(50)
DENTALFLUORO
Prostate Cancer
University Hospitals Cleveland Medical Center
P2
CCC
(50)
Ezetimibe
Prostate Cancer
Cedars-Sinai Medical Center
P2
CCC
(50)
Omacetaxine
Prostate Cancer
Zhongda Hospital
P2
CCC
(50)
(R)-(1-(4-FLUOROPHENYL)-6-((1-METHYL-1H-PYRAZOL-4-YL)SULFONYL)-1,4,5,6,7,8-HEXAHYDRO-4AH-PYRAZOLO(3,4-G)ISOQUINOLIN-4A-YL)(4-(TRIFLUOROMETHYL)PYRIDIN-2-YL)METHANONE
Prostate Cancer
University of Chicago
P2
CCC
(50)
Rosuvastatin
Prostate Cancer
Cedars-Sinai Medical Center
P2
CCC
(50)
SIMVASTATIN
Prostate Cancer
Cedars-Sinai Medical Center
P2
CCC
(50)
Urea
Prostate Cancer
Robert Bok, MD, PhD
P2
CCC
(50)
Enoblituzumab
Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
P2
CCC
(49)
gsk1120212
Prostate Cancer
OHSU Knight Cancer Institute
P2
CCC
(49)
fp-014
Prostate Cancer
Foresee Pharmaceuticals Co., Ltd.
P3
CCC
(48)
18F-ASIS
Prostate Cancer
Memorial Sloan Kettering Cancer Center
P2
CCC
(48)
1-PIPERIDINEETHANOL, .ALPHA.-((2-NITRO-1H-IMIDAZOL-1-YL)METHYL)-, HYDROCHLORIDE (1:1), (.ALPHA.R)-
Prostate Cancer
The Christie NHS Foundation Trust
P2
CCC
(48)
64cu-sar-bbn
Prostate Cancer
St Vincent's Hospital, Sydney
P2
CCC
(48)
Showing 126 to 150 of 395 assets
Previous
Page 6 of 16
Next